Peter Vermeulen

6.9k citations

79 papers · 4.0k indexed · h-index 35

Oncology top 1%
- Cancer Cells and Metastasis 22
- Colorectal Cancer Treatments and Studies 9
- Lymphatic System and Diseases 8
Cancer Research top 1%
- Cancer Genomics and Diagnostics 11
- Cancer, Hypoxia, and Metabolism 11
- Breast Cancer Treatment Studies 11
Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 15
Internal Medicine top 5%
Pulmonary and Respiratory Medicine top 5%
Molecular Biology
- Angiogenesis and VEGF in Cancer 23

Co-authors: Luc Dirix Peter A. van Dam Cécile Colpaert Steven Van Laere Gert G. Van den Eynden Eric A. Van Marck Ilse Van der Auwera Ina Benoy
Cited by: Oncology Cancer Research Hepatology
Journals: Journal of Clinical Oncology (2 papers)PLoS ONE (1 paper)JNCI Journal of the National Cancer Institute (2 papers)
Partner nations: Belgium Netherlands United Kingdom

In The Last Decade

Peter Vermeulen

77 papers receiving 3.9k citations

Peers

Countries citing papers authored by Peter Vermeulen

Since Specialization

Citations

This map shows the geographic impact of Peter Vermeulen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vermeulen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vermeulen more than expected).

Fields of papers citing papers by Peter Vermeulen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vermeulen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vermeulen. The network helps show where Peter Vermeulen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Vermeulen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Vermeulen Line = papers co-authored together Peter Vermeulen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study Breast Cancer Research ·Karen Van Baelen,Ha-Linh Nguyen,François Richard,Gitte Zels,Maria Margarete Karsten,Guilherme Nader Marta,Peter Vermeulen,Luc Dirix,Adam David Dordevic,Evandro de Azambuja,Denis Larsimont,Marion Maetens,Elia Biganzoli,Hans Wildiers,Ann Smeets,Ines Nevelsteen,Patrick Neven,Giuseppe Floris,Christine Desmedt	2025	1
2	Classifying histopathological growth patterns for resected colorectal liver metastasis with a deep learning analysis BJS Open ·Diederik J. Höppener,Witali Aswolinskiy,Zhen Qian,David Tellez,Pieter M. H. Nierop,Martijn P. A. Starmans,Irıs D. Nagtegaal,Michail Doukas,Johannes H.W. de Wilt,Dirk J. Grünhagen,Jeroen van der Laak,Peter Vermeulen,Francesco Ciompi,Cornelis Verhoef	2024	5
3	Spatial Transcriptome Mapping of the Desmoplastic Growth Pattern of Colorectal Liver Metastases by In Situ Sequencing Reveals a Biologically Relevant Zonation of the Desmoplastic Rim Clinical Cancer Research ·Axel Andersson,Maria Escriva Conde,Olga Surova,Peter Vermeulen,Carolina Wählby,Mats Nilsson,Hanna Nyström	2024	2
4	Molecular characterization of the histopathological growth patterns of colorectal cancer liver metastases by RNA sequencing of targeted samples at the tumor-liver interface Clinical & Experimental Metastasis ·Emily Latacz,Sanne M L Verheul,Yasmine Sillis,Pieter‐Jan van Dam,Michail Doukas,Dirk J. Grünhagen,Hanna Nyström,Piet Dirix,Luc Dirix,Steven Van Laere,Cornelis Verhoef,Peter Vermeulen	2024	0
5	Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers Frontiers in Oncology ·Ali Bohlok,François Richard,Valério Lucidi,Antoine El Asmar,Pieter Demetter,Ligia Craciun,Denis Larsimont,Alain Hendlisz,Jean‐Luc Van Laethem,Luc Dirix,Christine Desmedt,Peter Vermeulen,Vincent Donckier	2023	4
6	Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases British Journal of Cancer ·Pascale Mariani,Nouritza Torossian,Steven Van Laere,Peter Vermeulen,Leanne de Koning,Sergio Roman‐Roman,Olivier Lantz,Manuel Rodrigues,Marc‐Henri Stern,Sophie Gardrat,Laëtitia Lesage,Gabriel Champenois,Nicolás André,Alexandre Matet,Nathalie Cassoux,Vincent Servois,Emanuela Romano,Sophie Piperno‐Neumann,Claire Lugassy,Raymond L. Barnhill	2023	8
7	L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases Laboratory Investigation ·Raymond L. Barnhill,Steven Van Laere,Peter Vermeulen,Sergio Roman‐Roman,Sophie Gardrat,Samar Alsafadi,Malcy Tarin,Gabriel Champenois,Nicolás André,Alexandre Matet,Nathalie Cassoux,Vincent Servois,Manuel Rodrigues,Richard A. Scolyer,Alexander J. Lazar,Emanuela Romano,Sophie Piperno‐Neumann,Pascale Mariani,Claire Lugassy	2022	9
8	Generation of vessel co-option lung metastases mouse models for single-cell isolation of metastases-derived cells and endothelial cells STAR Protocols ·Anne Cuypers,Laure-Anne Teuwen,Victoria L. Bridgeman,Laura de Rooij,Guy Eelen,Mieke Dewerchin,Anna Rita Cantelmo,Joanna Kalucka,Ann Bouché,Stefan Vinckier,An Carton,Ann Manderveld,Peter Vermeulen,Andrew R. Reynolds,Peter Carmeliet	2022	1
9	Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study JNCI Cancer Spectrum ·Diederik J. Höppener,Boris Galjart,Pieter M. H. Nierop,Florian E. Buisman,Eric P. van der Stok,Robert R.J. Coebergh van den Braak,Martin J. van Amerongen,Vinod P. Balachandran,William R. Jarnagin,T. Peter Kingham,Michail Doukas,Jinru Shia,Irıs D. Nagtegaal,Peter Vermeulen,Bas Groot Koerkamp,Dirk J. Grünhagen,Johannes H.W. de Wilt,Michael I. D’Angelica,Cornelis Verhoef	2021	32
10	Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases Angiogenesis ·Boris Galjart,Pieter M. H. Nierop,Eric P. van der Stok,Robert R.J. Coebergh van den Braak,Diederik J. Höppener,Sofie Daelemans,Luc Dirix,Cornelis Verhoef,Peter Vermeulen,Dirk J. Grünhagen	2019	85
11	Angiotropism, pericytic mimicry and extravascular migratory metastasis: an embryogenesis-derived program of tumor spread Angiogenesis ·Claire Lugassy,Hynda K. Kleinman,Peter Vermeulen,Raymond L. Barnhill	2019	40
12	Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Molecular Cancer Therapeutics ·Victoria L. Bridgeman,Elaine Y. Wan,Shane Foo,Mark R. Nathan,Jonathan Welti,Sophia Frentzas,Peter Vermeulen,Natasha Preece,Caroline J. Springer,Thomas Powles,Paul Nathan,James Larkin,Martin Gore,Naveen Vasudev,Andrew R. Reynolds	2015	38
13	The Multifaceted Role of the Microenvironment in Liver Metastasis: Biology and Clinical Implications Cancer Research ·Gert G. Van den Eynden,Ali W. Majeed,Martin Illemann,Peter Vermeulen,Nigel C. Bird,Gunilla Høyer‐Hansen,Rikke Løvendahl Eefsen,Andrew R. Reynolds,Pnina Brodt	2013	171
14	Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes British Journal of Cancer ·Dieter Peeters,Pieter‐Jan van Dam,G G M Van den Eynden,Annemie Rutten,H Wuyts,Lieven Pouillon,Marc Peeters,Patrick Pauwels,Steven Van Laere,Peter A. van Dam,Peter Vermeulen,Luc Dirix	2013	59
15	Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer Clinical Cancer Research ·Gert G. Van den Eynden,Marcel Smid,Steven Van Laere,Cécile Colpaert,Ilse Van der Auwera,Trinh Xuan Bich,Peter A. van Dam,Michael A. den Bakker,Luc Dirix,Eric A. Van Marck,Peter Vermeulen,John A. Foekens	2008	23
16	Relapse-Free Survival in Breast Cancer Patients Is Associated with a Gene Expression Signature Characteristic for Inflammatory Breast Cancer Clinical Cancer Research ·Steven Van Laere,Tim Beißbarth,Ilse Van der Auwera,Gert Van den Eynden,Xuan Bich Trinh,Hilde Elst,Paul Van Hummelen,Peter A. van Dam,Eric Van Marck,Peter Vermeulen,Luc Dirix	2008	24
17	Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype British Journal of Cancer ·Ilse Van der Auwera,Steven Van Laere,Sandra M. van den Bosch,Gert G. Van den Eynden,B Trinh,Peter A. van Dam,Cécile Colpaert,Manon van Engeland,Eric A. Van Marck,Peter Vermeulen,Luc Dirix	2008	53
18	First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours British Journal of Cancer ·Ilse Van der Auwera,Yihai Cao,Jean‐Christophe Tille,Michael S. Pepper,David G. Jackson,Stephen B. Fox,Adrian L. Harris,Luc Dirix,Peter Vermeulen	2006	159
19	Endothelial cell apoptosis in the context of quantification of angiogenesis in solid human adenocarcinomas: A novel double immunolabelling technique to identify endothelial cell apoptosis European Journal of Cancer ·Koert P. de Jong,Peter Vermeulen,Eric Van Marck,Marcel Boot,Annette S.H. Gouw	2005	7
20	Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer British Journal of Cancer ·Gert G. Van den Eynden,Ilse Van der Auwera,Steven Van Laere,Cécile Colpaert,Helen Turley,Adrian L. Harris,Peter A. van Dam,Luc Dirix,Peter Vermeulen,Eric A. Van Marck	2005	48

About Peter Vermeulen

Peter Vermeulen is a scholar working on Hepatology, Cancer Research and Oncology, having authored 79 papers that have together received 4.0k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (23 papers), Cancer Cells and Metastasis (22 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cancer Genomics and Diagnostics (11 papers), Cancer, Hypoxia, and Metabolism (11 papers), Breast Cancer Treatment Studies (11 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lymphatic System and Diseases (8 papers). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (1.3k citations) and Hepatology (436 citations). Peter Vermeulen has collaborated with scholars based in Belgium, Netherlands and United Kingdom. Frequent co-authors include Luc Dirix, Peter A. van Dam, Cécile Colpaert, Steven Van Laere, Gert G. Van den Eynden, Eric A. Van Marck, Ilse Van der Auwera, Ina Benoy, Roberto Salgado and Eric Van Marck. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact